FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.10  |  FHIR Version n/a  User: [n/a]

332350005: Product containing precisely erythromycin 20 milligram/1 gram conventional release cutaneous gel (clinical drug)


Status: current, Sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jul 2018. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module
3693200014 Product containing precisely erythromycin 20 milligram/1 gram conventional release cutaneous gel (clinical drug) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
3693202018 Erythromycin 20 mg/g cutaneous gel en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core


0 descendants.

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Product containing precisely erythromycin 20 milligram/1 gram conventional release cutaneous gel (clinical drug) Is a Product containing erythromycin in topical dosage form false Inferred relationship Some
Product containing precisely erythromycin 20 milligram/1 gram conventional release cutaneous gel (clinical drug) Is a Product containing erythromycin in topical dosage form false Inferred relationship Some
Product containing precisely erythromycin 20 milligram/1 gram conventional release cutaneous gel (clinical drug) Has active ingredient Erythromycin (substance) false Inferred relationship Some
Product containing precisely erythromycin 20 milligram/1 gram conventional release cutaneous gel (clinical drug) Has active ingredient Bactericide false Inferred relationship Some
Product containing precisely erythromycin 20 milligram/1 gram conventional release cutaneous gel (clinical drug) Has manufactured dose form Cutaneous AND/OR transdermal dosage form false Inferred relationship Some
Product containing precisely erythromycin 20 milligram/1 gram conventional release cutaneous gel (clinical drug) Has manufactured dose form Cutaneous gel true Inferred relationship Some
Product containing precisely erythromycin 20 milligram/1 gram conventional release cutaneous gel (clinical drug) Has basis of strength substance (attribute) Erythromycin (substance) true Inferred relationship Some 1
Product containing precisely erythromycin 20 milligram/1 gram conventional release cutaneous gel (clinical drug) Has concentration strength denominator value 1 false Inferred relationship Some 1
Product containing precisely erythromycin 20 milligram/1 gram conventional release cutaneous gel (clinical drug) Has concentration strength numerator unit mg true Inferred relationship Some 1
Product containing precisely erythromycin 20 milligram/1 gram conventional release cutaneous gel (clinical drug) Has concentration strength numerator value 20 false Inferred relationship Some 1
Product containing precisely erythromycin 20 milligram/1 gram conventional release cutaneous gel (clinical drug) Has precise active ingredient Erythromycin (substance) true Inferred relationship Some 1
Product containing precisely erythromycin 20 milligram/1 gram conventional release cutaneous gel (clinical drug) Count of base of active ingredient 1 false Inferred relationship Some
Product containing precisely erythromycin 20 milligram/1 gram conventional release cutaneous gel (clinical drug) Has concentration strength denominator unit g true Inferred relationship Some 1
Product containing precisely erythromycin 20 milligram/1 gram conventional release cutaneous gel (clinical drug) Is a Product containing only erythromycin in cutaneous dose form (medicinal product form) true Inferred relationship Some
Product containing precisely erythromycin 20 milligram/1 gram conventional release cutaneous gel (clinical drug) Plays role Antibacterial therapeutic role (role) true Inferred relationship Some

Inbound Relationships Type Active Source Characteristic Refinability Group

This concept is not in any reference sets

Back to Start